SI3638370T1 - Tretiranje migrene z acetil-levcinom - Google Patents

Tretiranje migrene z acetil-levcinom

Info

Publication number
SI3638370T1
SI3638370T1 SI201830195T SI201830195T SI3638370T1 SI 3638370 T1 SI3638370 T1 SI 3638370T1 SI 201830195 T SI201830195 T SI 201830195T SI 201830195 T SI201830195 T SI 201830195T SI 3638370 T1 SI3638370 T1 SI 3638370T1
Authority
SI
Slovenia
Prior art keywords
migraine
leucine
acetyl
treatment
Prior art date
Application number
SI201830195T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael Strupp
Mallory Factor
Original Assignee
IntraBio Ltd, Summit House
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59358204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3638370(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by IntraBio Ltd, Summit House filed Critical IntraBio Ltd, Summit House
Publication of SI3638370T1 publication Critical patent/SI3638370T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201830195T 2017-06-14 2018-06-25 Tretiranje migrene z acetil-levcinom SI3638370T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1709459.0A GB201709459D0 (en) 2017-06-14 2017-06-14 Treatment for migraine
EP18749124.6A EP3638370B1 (en) 2017-06-14 2018-06-25 Treatment of migraine with acetyl-leucine
PCT/IB2018/054676 WO2018229738A1 (en) 2017-06-14 2018-06-25 Treatment for migraine

Publications (1)

Publication Number Publication Date
SI3638370T1 true SI3638370T1 (sl) 2021-04-30

Family

ID=59358204

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201830195T SI3638370T1 (sl) 2017-06-14 2018-06-25 Tretiranje migrene z acetil-levcinom

Country Status (25)

Country Link
US (1) US11471434B2 (enExample)
EP (1) EP3638370B1 (enExample)
JP (1) JP7130739B2 (enExample)
KR (1) KR102594130B1 (enExample)
CN (1) CN111093772B (enExample)
AU (1) AU2018284330B2 (enExample)
CY (1) CY1123860T1 (enExample)
DK (1) DK3638370T3 (enExample)
ES (1) ES2847169T3 (enExample)
GB (1) GB201709459D0 (enExample)
HR (1) HRP20210108T1 (enExample)
HU (1) HUE053089T2 (enExample)
IL (1) IL271211B2 (enExample)
LT (1) LT3638370T (enExample)
MA (1) MA49396B1 (enExample)
MD (1) MD3638370T2 (enExample)
MX (1) MX387909B (enExample)
PL (1) PL3638370T3 (enExample)
PT (1) PT3638370T (enExample)
RS (1) RS61481B1 (enExample)
SG (1) SG11201912146RA (enExample)
SI (1) SI3638370T1 (enExample)
SM (1) SMT202100037T1 (enExample)
WO (1) WO2018229738A1 (enExample)
ZA (1) ZA201908087B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3091353A1 (en) * 2018-02-15 2019-08-22 Intrabio Ltd Therapeutic agents for treating restless legs syndrome
BR112021010923A2 (pt) 2018-12-06 2021-08-24 Intrabio Ltd Análogos deuterados de acetileucina

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701662L (sv) * 1987-04-22 1988-10-23 Gelder Nico M Van Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
US20060063827A1 (en) 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
MY142655A (en) * 2003-06-12 2010-12-15 Euro Celtique Sa Therapeutic agents useful for treating pain
SI1641775T1 (sl) * 2003-07-03 2009-08-31 Euro Celtique Sa 2-piridin alkinski derivati, uporabni za zdravljenje bolečine
EP2080757A1 (en) * 2003-07-24 2009-07-22 Euro-Celtique S.A. Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
DE602004017481D1 (de) * 2003-09-22 2008-12-11 Euro Celtique Sa Zur behandlung von schmerzen geeignete therapeutische mittel
PT2017276E (pt) * 2003-09-22 2011-04-05 Euro Celtique Sa Compostos de fenilcarboxamida úteis para o tratamento da dor
CN1902178A (zh) * 2003-12-30 2007-01-24 欧洲凯尔特公司 用于治疗疼痛的哌嗪
FR2905600B1 (fr) * 2006-09-13 2010-01-15 Pf Medicament Traitement des vertiges par l'acetyl-l-leucine.
TN2010000251A1 (fr) 2010-06-03 2011-11-11 Rekik Raouf N-acetyl-dl-leucine medicament neuro et retino protecteur
JP5876423B2 (ja) * 2010-06-22 2016-03-02 塩野義製薬株式会社 Ｔｒｐｖ１阻害活性を有する化合物とその使用
EP2588130B1 (en) 2010-06-25 2016-08-17 Shire Human Genetic Therapies, Inc. Cns delivery of therapeutic agents
EP3536368B1 (en) * 2010-11-09 2025-09-17 MannKind Corporation Dry powder inhaler comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
AU2012293417A1 (en) * 2011-08-10 2013-05-02 Purdue Pharma L.P. TRPV1 antagonists including dihydroxy substituent and uses thereof
WO2017182802A1 (en) 2016-04-19 2017-10-26 Intrabio Ltd Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function
KR102467953B1 (ko) 2016-08-11 2022-11-16 인트라바이오 리미티드 리소좀 축적 질환과 관련된 약제 조성물 및 용도
MA43828B1 (fr) 2016-08-11 2019-09-30 Intrabio Ltd Agents thérapeutiques pour maladies neurodégénératives
WO2018178670A1 (en) 2017-03-28 2018-10-04 Intrabio Ltd Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject
MA50399A (fr) 2017-10-18 2020-08-26 Intrabio Ltd Agents thérapeutiques pour mobilité et fonction cognitive améliorées et pour le traitement de maladies neurodégénératives et de troubles de stockage lysosomal
SG11202003390UA (en) 2017-10-18 2020-05-28 Intrabio Ltd Therapeutic agents for neurodegenerative diseases
CA3091353A1 (en) 2018-02-15 2019-08-22 Intrabio Ltd Therapeutic agents for treating restless legs syndrome
BR112021010923A2 (pt) 2018-12-06 2021-08-24 Intrabio Ltd Análogos deuterados de acetileucina
KR20250171484A (ko) 2019-03-02 2025-12-08 인트라바이오 리미티드 질환을 치료하기 위한 류신, 아세틸 류신, 및 관련된 유사체
US20220362189A1 (en) 2019-06-28 2022-11-17 Intrabio Ltd. Combination therapy with acetyl-leucine and miglustat
WO2021144720A1 (en) 2020-01-13 2021-07-22 Intrabio Ltd Treatment of late-onset neurodegenerative diseases in heterozygous npc1 gene mutation carriers

Also Published As

Publication number Publication date
JP2020526575A (ja) 2020-08-31
IL271211A (en) 2020-01-30
WO2018229738A1 (en) 2018-12-20
MX2019014784A (es) 2021-11-16
US20200253905A1 (en) 2020-08-13
KR102594130B1 (ko) 2023-10-24
IL271211B1 (en) 2023-09-01
EP3638370A1 (en) 2020-04-22
PT3638370T (pt) 2021-01-26
MA49396A (fr) 2020-04-22
EP3638370B1 (en) 2020-11-11
KR20210013518A (ko) 2021-02-04
HRP20210108T1 (hr) 2021-03-19
US11471434B2 (en) 2022-10-18
CY1123860T1 (el) 2022-05-27
CN111093772A (zh) 2020-05-01
SG11201912146RA (en) 2020-01-30
LT3638370T (lt) 2021-03-25
AU2018284330A1 (en) 2020-01-02
HUE053089T2 (hu) 2021-06-28
DK3638370T3 (da) 2021-01-25
GB201709459D0 (en) 2017-07-26
SMT202100037T1 (it) 2021-03-15
RS61481B1 (sr) 2021-03-31
RU2020100475A (ru) 2021-07-14
CN111093772B (zh) 2023-11-03
IL271211B2 (en) 2024-01-01
ZA201908087B (en) 2024-11-27
CA3067321A1 (en) 2018-12-20
JP7130739B2 (ja) 2022-09-05
RU2020100475A3 (enExample) 2021-10-22
BR112019026660A2 (pt) 2020-07-14
PL3638370T3 (pl) 2021-05-17
MA49396B1 (fr) 2021-03-31
MX387909B (es) 2025-03-19
ES2847169T3 (es) 2021-08-02
AU2018284330B2 (en) 2024-03-14
MD3638370T2 (ro) 2021-04-30

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
IL261959B1 (en) Cancer treatment with tg02
IL264451B1 (en) A combination of abt-199 and achmetalstat for the treatment of aml
SG11201609652RA (en) Treatment of polybacterials infections
SI3558280T1 (sl) Preprečevanje in zdravljenje migrene
ZA201907401B (en) Treatment of adipocytes
GB201706406D0 (en) Method of treatment
EP3684342C0 (en) TREATMENT PROCEDURES
SI3661510T1 (sl) Postopki zdravljenja vedenjskih sprememb
GB201815588D0 (en) Method of treatment
GB201416832D0 (en) Methods of treatment
IL270362B (en) Glaucoma treatment
ZA201906319B (en) Methods of treating depression
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
SMT202100037T1 (it) Trattamento dell'emicrania con acetil-leucina
IL273543A (en) A new treatment for SMA
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201512139D0 (en) Methods of treatment
EP3157943A4 (en) Methods of treating or ameliorating migraine
GB201706817D0 (en) Treatment of migraines
GB201720439D0 (en) Method of treatment
GB201718589D0 (en) Method of treatment
GB201709554D0 (en) Method of treatment
SG10201913141UA (en) Treatment of alphavirus-induced inflammation
GB201603752D0 (en) Treatment of hypothyroidism